A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle.

CONTEXT FSH is essential for follicular maturation. Data from ovarian hyperstimulation cycles suggest that FSH action is attenuated by a frequent single nucleotide polymorphism of the FSH receptor gene exchanging Asn for Ser at codon 680. OBJECTIVE We hypothesized that the FSH receptor genotype influences menstrual cycle dynamics. DESIGN Menstrual cycle was monitored from the midluteal phase through ovulation until the consecutive menstruation. SETTING The study was conducted at the University research center. SUBJECTS Women homozygous for the Asn680 (n = 12) and Ser680 (n = 9) variants with normal menstrual cycles volunteered for the study. INTERVENTIONS There were no interventions. MAIN OUTCOME MEASUREMENTS Follicular growth, serum LH, FSH, estradiol, progesterone, inhibin A, inhibin B and antimullerian hormone were measured. RESULTS During the luteo-follicular transition, serum levels of estradiol, progesterone, and inhibin A were significantly lower, and FSH started to rise earlier in the Ser680/Ser680 group. FSH levels were steadily and significantly higher, and the mean area under the FSH curve was 31% greater in this group (P < 0.002). No differences were observed in estradiol, inhibin B, and growth velocities of dominant follicles. The time from luteolysis to ovulation was significantly longer in women with the Ser680/Ser680 (13.6 +/- 1.01 d) compared with Asn680/Asn680 (11.3 +/- 0.61 d, P < 0.05) genotype with a significant difference in total menstrual cycle length (29.3 vs. 27.0 d, respectively; P < 0.05). CONCLUSIONS The FSH receptor Ser680/Ser680 genotype is associated with higher ovarian threshold to FSH, decreased negative feedback of luteal secretion to the pituitary during the intercycle transition, and longer menstrual cycles.

[1]  L. Kiesel,et al.  Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation , 2005, Pharmacogenetics and genomics.

[2]  F. Morón,et al.  Human controlled ovarian hyperstimulation outcome is a polygenic trait. , 2004, Pharmacogenetics.

[3]  A. Loft,et al.  A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a 'standard' dose of 150 IU/day in 'standard' patients undergoing IVF/ICSI treatment. , 2003, Human reproduction.

[4]  L. Real,et al.  Role of follicle-stimulating hormone receptor Ser680Asn polymorphism in the efficacy of follicle-stimulating hormone. , 2003, Fertility and sterility.

[5]  R. Pierson,et al.  A new model for ovarian follicular development during the human menstrual cycle. , 2003, Fertility and sterility.

[6]  K. Loveland,et al.  Inhibins, activins and follistatin in reproduction. , 2002, Human reproduction update.

[7]  C. Welt,et al.  Activins, Inhibins, and Follistatins: From Endocrinology to Signaling. A Paradigm for the New Millennium , 2002, Experimental biology and medicine.

[8]  S. Sudo,et al.  Genetic and functional analyses of polymorphisms in the human FSH receptor gene. , 2002, Molecular human reproduction.

[9]  E. Nieschlag,et al.  Isoforms and single nucleotide polymorphisms of the FSH receptor gene: implications for human reproduction. , 2002, Human reproduction update.

[10]  B. Fauser,et al.  Antimüllerian hormone serum levels: a putative marker for ovarian aging. , 2002, Fertility and sterility.

[11]  B. Dahlbäck,et al.  Improved Hemoglobin Status and Reduced Menstrual Blood Loss among Female Carriers of Factor V Leiden – An Evolutionary Advantage? , 2001, Thrombosis and Haemostasis.

[12]  A. Zeleznik Follicle Selection in Primates: “Many Are Called but Few Are Chosen”1 , 2001, Biology of reproduction.

[13]  M. Eijkemans,et al.  Low-dose exogenous FSH initiated during the early, mid or late follicular phase can induce multiple dominant follicle development. , 2001, Human reproduction.

[14]  S. Ng,et al.  Absence of Mutations in the Coding Regions of Follicle-Stimulating Hormone Receptor Gene in Singapore Chinese Women with Premature Ovarian Failure and Polycystic Ovary Syndrome , 2001, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[15]  C. AbouZahr,et al.  Maternal mortality at the end of a decade: signs of progress? , 2001, Bulletin of the World Health Organization.

[16]  E. Nieschlag,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Ovarian Response to Follicle-Stimulating Hormone (FSH) Stimulation Depends on the FSH Receptor Genotype* , 2022 .

[17]  A. Hsueh,et al.  Initial and cyclic recruitment of ovarian follicles. , 2000, Endocrine reviews.

[18]  G. Conway,et al.  Mutation screening and isoform prevalence of the follicle stimulating hormone receptor gene in women with premature ovarian failure, resistant ovary syndrome and polycystic ovary syndrome , 1999, Clinical endocrinology.

[19]  E. Nieschlag,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Mutational Analysis of the Follicle-Stimulating Hormone (FSH) Receptor in Normal and Infertile Men: Identification and Characterization of Two Dis , 2022 .

[20]  J. Gromoll,et al.  Identification of allelic variants in the follicle-stimulating hormone receptor genes of females with or without hypergonadotropic amenorrhea. , 1998, Fertility and sterility.

[21]  B. Fauser,et al.  Lack of correlation between maximum early follicular phase serum follicle stimulating hormone concentrations and menstrual cycle characteristics in women under the age of 35 years. , 1998, Human reproduction.

[22]  W. Hop,et al.  The follicle-stimulating hormone (FSH) threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects follicle development. , 1998, The Journal of clinical endocrinology and metabolism.

[23]  E. Nieschlag,et al.  The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. , 1997, Endocrine reviews.

[24]  Yao-Tseng Chen,et al.  Follicle-stimulating hormone receptor is expressed in human ovarian surface epithelium and fallopian tube. , 1996, The American journal of pathology.

[25]  W. Hop,et al.  Decremental follicle-stimulating hormone and dominant follicle development during the normal menstrual cycle. , 1995, Fertility and sterility.

[26]  W. Hop,et al.  Growth patterns of nondominant ovarian follicles during the normal menstrual cycle. , 1990, Fertility and sterility.

[27]  D. Baird A model for follicular selection and ovulation: lessons from superovulation. , 1987, Journal of steroid biochemistry.

[28]  G. Hodgen The dominant ovarian follicle , 1982 .

[29]  James B. Brown,et al.  Pituitary Control of Ovarian Function — Concepts Derived from Gonadotrophin Therapy , 1978, The Australian & New Zealand journal of obstetrics & gynaecology.

[30]  Jacquelyn A. Mattfield Many Are Called, But Few Are Chosen. , 1972 .